AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $539,550 | -18.9% | 21,800 | -7.2% | 0.01% | -16.7% |
Q2 2023 | $665,520 | +117.8% | 23,500 | +76.7% | 0.01% | +100.0% |
Q1 2023 | $305,501 | -17.6% | 13,300 | +0.8% | 0.00% | -25.0% |
Q4 2022 | $370,656 | -3.6% | 13,200 | -2.9% | 0.00% | 0.0% |
Q3 2022 | $384,608 | -36.2% | 13,600 | -34.3% | 0.00% | -33.3% |
Q1 2022 | $603,000 | -31.0% | 20,700 | -22.2% | 0.01% | 0.0% |
Q4 2021 | $874,000 | -38.9% | 26,600 | -14.2% | 0.01% | -60.0% |
Q3 2021 | $1,431,000 | -46.5% | 31,000 | -36.1% | 0.02% | -42.3% |
Q2 2021 | $2,673,000 | +156.3% | 48,500 | +140.1% | 0.03% | +160.0% |
Q1 2021 | $1,043,000 | +19.2% | 20,200 | 0.0% | 0.01% | +11.1% |
Q4 2020 | $875,000 | +8.7% | 20,200 | -12.2% | 0.01% | 0.0% |
Q3 2020 | $805,000 | -47.4% | 23,000 | -19.6% | 0.01% | -50.0% |
Q2 2020 | $1,530,000 | +45.7% | 28,600 | -3.4% | 0.02% | +28.6% |
Q1 2020 | $1,050,000 | +3.2% | 29,600 | +39.0% | 0.01% | +27.3% |
Q4 2019 | $1,017,000 | +110.1% | 21,300 | +119.6% | 0.01% | +83.3% |
Q2 2019 | $484,000 | +59.7% | 9,700 | +115.6% | 0.01% | +50.0% |
Q1 2019 | $303,000 | – | 4,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |